Biozorb
BioZorb Risks and Your Legal Rights
Discover the truth about Biozorb risks post-breast implant. Learn about legal options for compensation.
BioZorb MRI Safety Concerns: Legal Options
Navigate Biozorb MRI safety post-surgery. Learn about risks, legal options, and how to protect yourself.
BioZorb Side Effects and FDA Approval: Legal Options
Facing Biozorb side effects? Explore the role of FDA approval and your legal options with Legal Claim Assistant Inc.
File a Legal Claim for Breast Biopsy Marker Side Effects
Discover the truth about breast biopsy marker side effects. Learn about long-term concerns and legal rights.
The Biozorb breast marker lawsuit is a significant legal development concerning a medical device used to mark tissue for post-operative radiation in breast cancer patients. Plaintiffs allege that the Biozorb marker, manufactured by Hologic, failed to dissolve as intended, leading to complications such as pain, infection, device migration, and erosion.
These lawsuits gained momentum after the FDA issued a Class 1 recall for Biozorb markers in October 2024, the most serious type of recall indicating a risk of serious injury or death. The FDA’s warning letter to Hologic in December 2024 highlighted concerns about manufacturing processes, quality control, and failure to report adverse events adequately.